Showing results (6491-6500 of 14,847) with videos related to

Sort By:
Pageof 1,485
Pharmaceutics|July 27, 2022
Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic ReviewShista Priyadarshini, Derek B Allison, Aman Chauhan
Pharmaceutics|July 27, 2022
Removal of Circulating Tumor Cells from Blood Samples of Cancer Patients Using Highly Magnetic Nanoparticles: A Translational Research ProjectSimon Doswald, Antoine F Herzog, Martin Zeltner, et al.
Pharmaceutics|July 27, 2022
Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico ExperimentationPaul A Valle, Raul Garrido, Yolocuauhtli Salazar, et al.
Pharmaceutics|July 27, 2022
Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma TreatmentMiriam Ana González-Cela-Casamayor, José Javier López-Cano, Irene Bravo-Osuna, et al.
Pharmaceutics|July 27, 2022
Drug-Drug Interactions with Oral Anticoagulants as Potentially Inappropriate Medications: Prevalence and Outcomes in Elderly Patients in Primary Care and Hospital SettingsMathilde Bories, Guillaume Bouzillé, Marc Cuggia, et al.
Pharmaceutics|July 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-αAngelo Corti, Teresa Calimeri, Flavio Curnis, et al.
Pharmaceutics|July 27, 2022
"Endothelial Antibody Factory" at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative DiseasesReynald Thinard, Attila E Farkas, Marta Halasa, et al.
Pharmaceutics|July 27, 2022
Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical TechniquesRashed M Almuqbil, Nagaraja Sreeharsha, Anroop B Nair
Pharmaceutics|July 27, 2022
Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials OfficeDiego Alejandro Dri, Elisa Gaucci, Ilaria Torrieri, et al.
Pharmaceutics|July 27, 2022
Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral ImmunityYan Mu, Xiao-He Ren, Di Han, et al.
Pageof 1,485